Characterising a New Cannabis Trend: Extensive Analysis of Semi‐Synthetic Cannabinoid‐Containing Seizures From Germany
Open Access
- 19 March 2025
- journal article
- Published by Wiley in Drug Testing and Analysis
- Vol. 17 (9) , 1803-1816
Abstract
In May 2022, semi‐synthetic cannabinoids (SSC) appeared on the European drug market, claiming to offer a legal alternative with cannabimimetic effects. Since then, the use of hexahydrocannabinol (HHC) has quickly become very popular and derivatives, among them heptyl‐analogs with prolonged alkyl‐sidechains and acetylated forms, have appeared. First HHC‐bans were introduced in some EU countries in early 2023. As only limited data is available on this dynamic consumption trend, this study aims to analyse a seizure collective comprehensively.A liquid chromatography–tandem mass spectrometry method was validated for quantification of (R,S)‐HHC, Δ8‐THC, Δ9‐THC, CBD, CBG, CBN, (R,S)‐HHC‐O and CBN‐O and applied to a collective of 80 SSC‐containing products including flowers, resins, edibles, vape liquids and papers. Further derivatives, among them (R,S)‐HHCP, Δ9‐THCP, Δ8‐THCP, (R,S)‐HHCP‐O, (R,S)‐H4CBD, THC‐O and THCP‐O were qualitatively evaluated.HHC‐content was characterised by extreme fluctuations from 9‐THC was detected in most seizures, with around a quarter of samples exceeding the EU‐legal limit for hemp (< 0.3 wt‐% Δ9‐THC). Δ8‐THC was rarely found in elevated levels which might indicate residues of HHC‐synthesis. H4CBD was the most frequently detected SSC‐derivative, followed by heptyl‐analogs. Acetates played a minor role and were usually only detected in traces, while elevated levels occurred rarely. Unusual cannabinoid compositions were detected in cannabis carrier material, including extreme CBD‐concentrations (up to 67.3 wt‐%) and CBG‐dominant cultivars.Systematic investigation of seizures provides information for assessing the risk to consumers and is a valuable basis for the interpretation of findings in biological material.Keywords
This publication has 34 references indexed in Scilit:
- Isolation and characterization of synthesis intermediates and side products in hexahydrocannabiphorolDrug Testing and Analysis, 2024
- Δ9-Tetrahydrocannabiphorol: Identification and quantification in recreational productsForensic Chemistry, 2024
- In vitro activation of the CB1 receptor by the semi‐synthetic cannabinoids hexahydrocannabinol (HHC), hexahydrocannabinol acetate (HHC‐O) and hexahydrocannabiphorol (HHC‐P)Drug Testing and Analysis, 2024
- Human metabolism of the semi‐synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samplesDrug Testing and Analysis, 2024
- Comprehensive cannabinoid profiling of acid-treated CBD samples and Δ8-THC-infused ediblesFood Chemistry, 2023
- The first LC-MS/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urineJournal of Pharmaceutical and Biomedical Analysis, 2023
- A Comprehensive Review of Cannabis Potency in the United States in the Last DecadeBiological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2021
- Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines – Identification of potential distinguishing markersForensic Science International, 2021
- (−)-trans-Δ9-Tetrahydrocannabiphorol Content of Cannabis sativa Inflorescence from Various ChemotypesJournal of Natural Products, 2021
- Validation of new methodsForensic Science International, 2007